Concepedia

Arik A. Zur

AA

Statistics

Publications

9

Citations

684

H-Index

9

Active since

2012

Affiliations

University of California, San Francisco(Current)

Icahn School of Medicine at Mount Sinai

University of Nebraska at Kearney

QB3

Optivia Biotechnology (United States)

Arik A. Zur is an author at University of California, San Francisco specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

2012–2020

9

Publications

9

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Ligong Chen, Yan Shu, Xiaomin Liang et al. · Proceedings of the National Academy of Sciences · 2014 · 237 citations · Full text

, , +17

Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling

Matthias Wittwer, Arik A. Zur, Natalia Khuri et al. · Journal of Medicinal Chemistry · 2012 · 142 citations · Full text

, , +12

Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)

Huan‐Chieh Chien, Claire Colas, Karissa Finke et al. · Journal of Medicinal Chemistry · 2018 · 81 citations · Full text

, , +17

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

Jennifer Hibma, Arik A. Zur, Richard A. Castro et al. · Clinical Pharmacokinetics · 2015 · 58 citations · Full text

, , +3

LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs

Evan Augustyn, Karissa Finke, Arik A. Zur et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 47 citations · Full text

, , +8

1–5 of 9